PMID- 31914858 OWN - NLM STAT- MEDLINE DCOM- 20211007 LR - 20211007 IS - 1557-9042 (Electronic) IS - 0897-7151 (Linking) VI - 37 IP - 10 DP - 2020 May 15 TI - Curcumin Protects against White Matter Injury through NF-kappaB and Nrf2 Cross Talk. PG - 1255-1265 LID - 10.1089/neu.2019.6749 [doi] AB - Inflammation and oxidative stress play a central role in the pathogenesis of white matter injury (WMI). Curcumin (Cur), a polyphenolic compound, exhibits anti-inflammatory and anti-oxidant effects on several conditions. The objective of this study was to investigate neuroprotective effects of Cur on WMI and explore its underlying mechanisms of action. Sprague-Dawley rats were subjected to the removal of white matter from the dorsal column of the spinal cord. Dorsal columns were randomly divided into three groups: Sham (Ringer's solution bubbled with 95% O(2) and 5% CO(2)), hypoxia (Hyp; Ringer's solution bubbled with 95% N(2) and 5% CO(2) for 1 h), and Cur-treated (Hyp+Cur; Ringer's solution bubbled with 95% N(2) and 5% CO(2) for 1 h in the presence of 50 muM Cur). For NF-kappaB inhibition experiments, dorsal columns were incubated with 50 muM BAY 11-7082 (BAY) for 30 min in 95% O(2) and 5% CO(2) prior to 1-h incubation with 50 muM Cur in 95% N(2) and 5% CO(2). Our data show that Cur inhibited hypoxia-induced HIF1-alpha expression and tissue damage by demonstrating the improved morphology of astrocytes and remarkable reduction in vacuolation. Cur also inhibited the hypoxia-induced upregulation of glial fibrillary acidic protein (GFAP) and neurofilament-H (NF-H) after hypoxia and downregulated the expression of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin 1 (IL-1). Terminal dexynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-assay analysis showed that Cur effectively attenuated apoptosis in white matter. In addition, we demonstrated that Cur exerted its neuroprotective effect through cross talk between nuclear factor kappa-light-chain-enhancer of activated B (NF-kappaB) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways. In conclusion, our results indicate that treatment with Cur inhibited the hypoxia, inflammation and apoptosis associated with WMI. Further, the Nrf-2 pathway inhibits NF-kappaB activation by preventing IkB degradation and increasing HO-1 expression, which in turn reduces reactive oxygen species (ROS) and as a result NF-kappaB activation is suppressed. Similarly, NF-kappaB-mediated transcription reduces Nrf2 activation by reducing anti-oxidant response element (ARE) gene and free CREB binding protein by competing with Nrf2 for CBP thus inhibiting the Nrf-2 activation. FAU - Daverey, Amita AU - Daverey A AD - Department of Neurosurgery, University of Nebraska Medical Center, Omaha, Nebraska, USA. FAU - Agrawal, Sandeep K AU - Agrawal SK AD - Department of Neurosurgery, University of Nebraska Medical Center, Omaha, Nebraska, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200205 PL - United States TA - J Neurotrauma JT - Journal of neurotrauma JID - 8811626 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (NF-E2-Related Factor 2) RN - 0 (NF-kappa B) RN - 0 (Neuroprotective Agents) RN - 0 (Nfe2l2 protein, rat) RN - IT942ZTH98 (Curcumin) SB - IM MH - Animals MH - Anti-Inflammatory Agents, Non-Steroidal/*pharmacology MH - Cell Hypoxia/drug effects/physiology MH - Curcumin/*pharmacology MH - Male MH - NF-E2-Related Factor 2/*metabolism MH - NF-kappa B/antagonists & inhibitors/*metabolism MH - Neuroprotective Agents/pharmacology MH - Organ Culture Techniques MH - Oxidative Stress/drug effects/physiology MH - Rats MH - Rats, Wistar MH - Spinal Cord/drug effects/metabolism MH - White Matter/*drug effects/injuries/*metabolism OTO - NOTNLM OT - curcumin OT - hypoxia OT - oxidative stress OT - polyphenolic compounds OT - spinal cord injury OT - white matter EDAT- 2020/01/10 06:00 MHDA- 2021/10/08 06:00 CRDT- 2020/01/10 06:00 PHST- 2020/01/10 06:00 [pubmed] PHST- 2021/10/08 06:00 [medline] PHST- 2020/01/10 06:00 [entrez] AID - 10.1089/neu.2019.6749 [doi] PST - ppublish SO - J Neurotrauma. 2020 May 15;37(10):1255-1265. doi: 10.1089/neu.2019.6749. Epub 2020 Feb 5.